戻る Agenda
Herbal-induced Liver Injury (HILI): How That May Impact Rx Benefit-Risk
Session Chair(s)
Pradip Paul, MD, MS
Consultant
Strategic Pharmacovigilance and Risk Management, United States
Natural health products (NHP) safety plays an important role in the possible risk assessment of a compound under development or a product in the market. This important noise can be reduced, and recalibration of internal evaluation processes is needed.
This session has been developed by the Natural Health Products (NHP) Community.
Learning Objective : Discuss the role of natural health products in risk assessment; Describe the importance of the internal review process.
Speaker(s)
Herbal Induced Liver Injury (HILI); Epidemiology and Regulation of the Use of Herbals
Leonard B. Seeff, MD
Former VA, FDA and Hill Group, United States
Consultant in Hepatology
Herbal-Induced Liver Injury (HILI): Overview
Victor J. Navarro, MD
Einstein Medical Center, United States
Chair, Hepatology
Rx Benefit-risk May be Impacted by Herbal-induced Liver Injury (HILI)
Pradip Paul, MD, MS
Strategic Pharmacovigilance and Risk Management, United States
Consultant